Serum concentration of oral midazolam as pediatric preanesthetic medication and factors related to the sedation level
Authors:
- 13 May 2022
- journal article
- research article
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 66 (7) , 818-822
Abstract
Background: Preanesthetic medication is important to eliminate surgical anxiety in pediatric patients and facilitate their smooth transfer to the operating room. Midazolam is the most commonly used preanesthetic medication. However, it has been reported that the sedative effect varies from patient to patient. In this study, the pharmacokinetics of midazolam were examined, and the aim was to assess the factors affecting the quality of sedation.Methods: The participants were children ranging in age from 6 months to 8 years scheduled for surgery. Midazolam 0.5 mg/kg was administered orally 30 min before entering the operating room, and the sedation level was evaluated at the time of mask application. Blood was collected after slow induction, and the serum concentration of midazolam was measured using high‐performance liquid chromatography.Results: A total of 98 patients were registered. There was no difference in serum concentrations between the effective sedation group and the ineffective sedation group (48.0 vs. 49.1 ng/mL), regardless of the effect of midazolam. Percentages of ineffective sedation by age (0 to 7 years) were 66.6%, 60%, 33.3%, 11.1%, 0%, 0%, 12.5%, and 0%, respectively. On multivariate logistic regression analysis, siblings (OR = 3.9, CI: 1.1–14.0, p = .03) and age (OR = 3.2, CI:1.2–8.5, p = .02) were related to an insufficient sedative effect.Conclusion: The serum concentration of oral midazolam reached effective levels even in patients in whom the sedative effect was inadequate. It is important to manage the perioperative period with appropriate concurrent premedication taking into account patient age and social background characteristics.Clinical trial registration: Clinical trial registry: UMIN R000052504.Keywords
Funding Information
- Kitasato University
This publication has 16 references indexed in Scilit:
- Perioperative anxiety in childrenPediatric Anesthesia, 2010
- Validation of a new HPLC method for determination of midazolam and its metabolites: Application to determine its pharmacokinetics in human and measure hepatic CYP3A activity in rabbitsJournal of Pharmaceutical and Biomedical Analysis, 2009
- An evidence-based review of parental presence during anesthesia induction and parent/child anxietyCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 2008
- Effects of Age and Emotionality on the Effectiveness of Midazolam Administered Preoperatively to ChildrenAnesthesiology, 2007
- Developmental Pharmacology — Drug Disposition, Action, and Therapy in Infants and ChildrenNew England Journal of Medicine, 2003
- Midazolam Premedication in Children: A Comparison of Two Oral Dosage Formulations on Sedation Score and Plasma Midazolam LevelsAnesthesia & Analgesia, 2003
- The Single‐Dose Pharmacokinetics of Midazolam and Its Primary Metabolite in Pediatric Patients after Oral and Intravenous AdministrationThe Journal of Clinical Pharmacology, 2001
- Oral Midazolam Preanesthetic Medication in Pediatric OutpatientsAnesthesiology, 1990
- The pharmacokinetics of midazolam in paediatric patientsEuropean Journal of Clinical Pharmacology, 1989
- AGE AND NATURE OF OPERATION INFLUENCE THE PHARMACOKINETICS OF MIDAZOLAMBritish Journal of Anaesthesia, 1985